•  
  •  
  •  
  •  

2025-12-29 21:10:14

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Niraj Cement Structurals Ltd receives order worth Rs. 96.12 crores
  • Cosmo First Appoints Saurabh Jain as CEO of Pet Care Division, Zigly and Head of Corporate Development
  • Nifty Extends Losses for Third Day, Consumer Durables and IT Lead the Decline
  • IDFC FIRST Bank Unveils Gaj: - An Invitation-Only Metal Masterpiece for IDFC Private Banking Customers
  • Lupin signs exclusive licensing agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist

Keywords Selected:  BharatParenterals

Stock Report

  • Innoxel Lifesciences Successfully Completes EU GMP Inspection by Belgium's FAMHP
  • Bharat Parenterals Ltd consolidated Q1FY26 loss reduces to Rs. 87 lakhs
  • Bharat Parenterals Limited recommends final dividend of Rs. 1
  • Bharat Parenterals Ltd Q4FY25 consolidated loss widens to Rs. 4.73 crore
  • Innoxel Lifesciences Pvt. Ltd. Successfully Completes U.S. FDA Inspection
  • Bharat Parenterals Ltd consolidated Q1 FY2023-24 net profit zooms to Rs. 7.52 crores
  • Bharat Parenterals Ltd Q4 FY2022-23 consolidated net profit slips to Rs. 2.49 crore
  • Bharat Parenterals Ltd Q1FY23 consolidated profit slides to Rs. 1.17 crore
  • Bharat Parenterals Ltd Q4 FY22 consolidated PAT jumps to Rs. 4.04 crores
  • Bharat Parenterals Q3FY22 consolidated PAT plunges to Rs. 1.33 crore
  • Bharat Parenterals Ltd posts higher consolidated PAT of Rs. 7.95 crore in Q2FY22

Latest Post

  • Niraj Cement Structurals Ltd receives order worth Rs. 96.12 crores
  • Cosmo First Appoints Saurabh Jain as CEO of Pet Care Division, Zigly and Head of Corporate Development
  • Nifty Extends Losses for Third Day, Consumer Durables and IT Lead the Decline
  • IDFC FIRST Bank Unveils Gaj: - An Invitation-Only Metal Masterpiece for IDFC Private Banking Customers
  • Lupin signs exclusive licensing agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024